Share on :

Asset Summary

No data available for Daily Sep 17, 2024, .

Asset Performance Metrics and Risk Characteristics:

Understanding asset performance is crucial for evaluating investment quality and making informed decisions. Metrics like trailing return and drawdown provide insights into how an asset has performed over time, its volatility, and the efficiency of its returns relative to risk. Performance indicators help assess the stability, risk, and reward of an investment, allowing investors and portfolio managers to make comparisons and strategize accordingly.

Asset Technical Analysis

Technical analysis involves evaluating an asset's price and volume data to forecast future movements and make informed trading decisions. By using various technical indicators and chart patterns, investors can gain insights into market trends, price momentum, and potential turning points. This section delves into essential technical metrics, including moving averages, pivot points, and other indicators that provide a snapshot of an asset's current technical stance. Analyzing these indicators helps investors identify entry and exit points, assess market sentiment, and refine their trading strategies. Explore the following technical analysis data to understand the asset's performance dynamics and make better-informed decisions.

Moving Averages

Moving Averages are commonly used to smooth out price data and identify trends over a specific period. Here’s a summary of the latest moving averages for various periods:

  • SMA (Simple Moving Average): Reflects the average price over a specific number of periods.
  • EMA (Exponential Moving Average): Gives more weight to recent prices, making it more responsive to new information.
  • WMA (Weighted Moving Average): Assigns a weight to each price, emphasizing more recent prices.
  • WEMA (Weighted Exponential Moving Average): Combines elements of both WMA and EMA for a more responsive moving average.

Advance Your LABD Trading Now

Revolutionize your investment in LABD with Rank My Trade Online’s innovative trading solutions. Benefit from our comprehensive risk management features and sophisticated price analysis tools. Start optimizing your trades today with Rank My Trade Online now and achieve better trading outcomes!

Get Advanced Analysis Now

Frequently Asked Questions

LABD aims to deliver three times the inverse (-3x) of the daily performance of the S&P Biotechnology Select Industry Index. Over time, due to the effects of compounding and daily rebalancing, its performance may differ significantly from the index.

LABD is managed by Direxion Funds and employs leverage through financial instruments such as futures contracts, options, and swap agreements. The fund aims to maintain its -3x leverage ratio through daily rebalancing.

LABD uses leverage to amplify its inverse exposure to the biotech sector, targeting -3x the daily performance of the S&P Biotechnology Select Industry Index. Leverage can lead to significant performance fluctuations, particularly over periods longer than one day due to compounding effects.

Yes, LABD can be held in retirement accounts such as IRAs or 401(k)s. However, due to its high-risk, leveraged nature, it is essential to consider how it fits within your overall investment strategy and risk tolerance.

LABD typically distributes dividends on a quarterly basis. These dividends come from income generated by the underlying securities, although leveraged ETFs like LABD may have lower yields compared to non-leveraged funds.

Key performance metrics for LABD include its net asset value (NAV), expense ratio, daily return performance, and leverage ratio. LABD targets -3x the daily performance of the S&P Biotechnology Select Industry Index.

Factors influencing LABD’s performance include movements in the biotech sector, changes in the S&P Biotechnology Select Industry Index, market volatility, and the effects of leverage. LABD’s daily rebalancing and compounding effects also impact performance.

Similar ETFs to LABD include: LABU (Direxion Daily S&P Biotech Bull 3X Shares), which seeks to provide 3x the daily performance of the S&P Biotechnology Select Industry Index, the opposite of LABD’s objective; XBI (SPDR S&P Biotech ETF), which provides exposure to the biotechnology sector without leverage; and BIB (Direxion Daily S&P Biotech Bull 2X Shares), which provides 2x the daily performance of the S&P Biotechnology Select Industry Index, less leveraged compared to LABD.

LABD has an expense ratio of approximately 1.07%. This fee covers the costs of managing the fund, including administrative and operational expenses, expressed as a percentage of the fund’s average net assets.

Risks include high volatility and potential for significant losses due to LABD’s leveraged inverse exposure. The ETF's performance is highly sensitive to daily movements in the biotech sector, and leverage can amplify both gains and losses.

Advance Your LABD Trading Now

Experience the future of trading with Rank My Trade. Our advanced system delivers in-depth analysis and insights for LABD, utilizing state-of-the-art technical tools and strategies. Transform your trading strategy now and see how we can elevate your trading results!

Disclaimers

The information displayed on this site is sourced from third-party providers and is believed to be reliable. RankMyTrade (RMT) has not independently verified this data and does not guarantee its accuracy. The information and calculations provided by RankMyTrade are for educational and informational purposes only and should not be construed as financial or investment advice.

With any investment, your capital is at risk. The value of your portfolio go down as well as up. Past performance is no guarantee of future results. By using this website, you accept our Terms of Service, Privacy Policy, and Payment Agreement.

Market data is provided in near real-time when available, but we do not guarantee its accuracy or timeliness.

Securities products are: Not FDIC insured · Not bank guaranteed · May lose value

Trademarks and logos are the property of their respective owners and do not represent endorsements of any kind. Unless otherwise noted, RankMyTrade and its affiliates are not partners, affiliates, or licensees of these companies.

Supported Assets & ETFs